All medicines centrally authorised in the EU (EMA)
golimumab
aflibercept
single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal domain and receptor-binding domain of the viral spike (S) protein of SARS-CoV-2
apremilast
inclisiran
sotrovimab
ozanimod hydrochloride
zolbetuximab
L-acetylleucine
filgrastim
velmanase alfa
lotilaner;milbemycin oxime
fingolimod hydrochloride
aliskiren
Piflufolastat (18F)
trastuzumab
desloratadine
aprocitentan
olanzapine
Page 37 of 134 • 20 of 2,678 Medicines